Get started
Bayer A.G.Bayer A.G.Bayer A.G.

Bayer A.G.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

BAYZF chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
2.50USD
Revenue estimate
‪15.32 B‬USD

Key stats

Market capitalization
‪28.34 B‬USD
Dividend yield (indicated)
0.41%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.30USD
Net income (FY)
‪−3.25 B‬USD
Revenue (FY)
‪52.58 B‬USD
Shares float
‪952.09 M‬
Beta (1Y)
0.91

About BAYER AG NA O.N.

Sector
Health Technology
CEO
William N. Anderson
Headquarters
Leverkusen
Website
bayer.com
Employees (FY)
‪99.72 K‬
Founded
1952
ISIN
DE000BAY0017
FIGI
BBG000BX92S0
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where BAYZF is featured.

See all sparks 

Frequently Asked Questions

The current price of BAYZF is 29.08 USD — it has increased by 0.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bayer A.G. stocks are traded under the ticker BAYZF.
Bayer A.G. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
BAYZF stock is 0.33% volatile and has beta coefficient of 0.91. Check out the list of the most volatile stocks — is Bayer A.G. there?
BAYZF earnings for the last quarter are 0.40 USD per share, whereas the estimation was 0.80 USD resulting in a −49.97% surprise. The estimated earnings for the next quarter are 1.59 USD per share. See more details about Bayer A.G. earnings.
Bayer A.G. revenue for the last quarter amounts to ‪10.93 B‬ USD despite the estimated figure of ‪11.22 B‬ USD. In the next quarter revenue is expected to reach ‪12.92 B‬ USD.
Yes, you can track Bayer A.G. financials in yearly and quarterly reports right on TradingView.
BAYZF stock has risen by 4.34% compared to the previous week, the month change is a 3.42% fall, over the last year Bayer A.G. has showed a 55.76% decrease.
BAYZF net income for the last quarter is ‪1.48 B‬ USD, while the quarter before that showed ‪−4.83 B‬ USD of net income which accounts for 130.55% change. Track more Bayer A.G. financial stats to get the full picture.
Today Bayer A.G. has the market capitalization of ‪28.34 B‬, it has increased by 5.06% over the last week.
Yes, BAYZF dividends are paid annually. The last dividend per share was 2.64 USD. As of today, Dividend Yield (TTM)% is 8.92%. Tracking Bayer A.G. dividends might help you take more informed decisions.
Like other stocks, BAYZF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bayer A.G. stock right from TradingView charts — choose your broker and connect to your account.
BAYZF reached its all-time high on Dec 28, 2007 with the price of 920.00 USD, and its all-time low was 21.20 USD and was reached on Aug 27, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has ‪99.72 K‬ employees. See our rating of the largest employees — is Bayer A.G. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bayer A.G. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bayer A.G. stock shows the sell signal. See more of Bayer A.G. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Bayer A.G. future price: according to them, BAYZF price has a max estimate of 65.43 USD and a min estimate of 26.82 USD. Read a more detailed Bayer A.G. forecast: see what analysts think of Bayer A.G. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bayer A.G. EBITDA is ‪13.38 B‬ USD, and current EBITDA margin is 25.91%. See more stats in Bayer A.G. financial statements.